CHICAGO (EGMN) - Interim analysis shows a very low rate of posttransplant relapse in the first prospective study of fludarabine-based, reduced-intensity conditioning for allogeneic stem cell transplant from matched donors in intermediate- or high-risk patients with myelofibrosis. "So far, we have analyzed 58 patients out of 64," said principal investigator Dr. Damiano Rondelli of the University of Illinois at Chicago, who presented the analysis in a poster at the annual meeting of the American Society...